Coordinating Initiatives to Enhance CRM Care

Key Takeaways

Collaboration among stakeholders is essential for improving CRM care and aligning initiatives with shared goals.
Value-based care models incentivize healthcare providers to focus on patient outcomes, enhancing care quality for CRM conditions.
Financial support from pharmaceutical companies can drive research, education, and technology integration in CRM care.
Effective communication and data sharing are critical for measuring success and optimizing resource utilization in CRM care.

Experts examine strategies for coordinating initiatives to enhance cardiometabolic risk management care, focusing on incentivizing providers to deliver high-quality care to patients with cardiometabolic conditions.

EP: 1.The Impact of CRM Diseases in the US: Burden, Prevalence, and Obesity

EP: 2.Strategies for Prevention and Screening of CRM Conditions

EP: 3.The Link Between Obesity and CRM Conditions

EP: 4.Challenges in Managing Co-Morbid CRM Conditions

EP: 5.Contemporary Guidelines for CRM Conditions

EP: 6.Reasons for Low Adherence to Guidelines for CRM Conditions

EP: 7.Overcoming Barriers to Prescribing First-Line Medications for CRM Conditions

EP: 8.Educational Initiatives to Enhance Guideline Adherence in CRM

EP: 9.Addressing Gaps in CKD, T2D, and CVD Guidelines

EP: 10.Care Coordination for High-Risk CRM Patients

EP: 11.Takeaways from the UH CINEMA Program

EP: 12.Exploring the Kidney-CHAMP Study

EP: 13.Insights from the COORDINATE-Diabetes Trial

Now Viewing

EP: 14.Coordinating Initiatives to Enhance CRM Care

Video content above is prompted by the following:

How can we help coordinate initiatives, like those we just heard from, to improve CRM care and the value of care provided?
How can healthcare providers be incentivized to provide high quality care to patients with CRM conditions?

This activity is supported by Boehringer Ingelheim Pharmaceuticals Inc. and Eli Lilly and Company who provided financial support for this program.